Indian Council of Medical Research (ICMR) said “it is envisaged to launch” an indigeneous vaccine for the novel coronavirus diseaes (COVID-19) by August 15, 2020.
- ICMR Director-General Balram Bhargava wrote in a letter that the Council has partnered Bharat Biotech International Ltd to fast track clinical trials of the ‘BBV152 COVID vaccine’.
- The two organisations were jointly working for the preclinical and clinical development of the vaccine, he said.
- The vaccine is derived from a SARS-CoV-2 strain isolated by ICMR-National Institute of Virology, Pune, according to Bhargava’s letter.
- The letter was sent to the heads of the following institutes selected as clinical trial sites of the vaccine:
- King George Hospital, Vishakhapatnam
- University of Health Sciences, Rohtak
- All-India Institute of Medical Sciences (AIIMS), New Delhi
- AIIMS, Phulwarisharif
- Jeevan Rekha Hospital, Belagavi
- Gillurkar Multispecialty Hospital, Nagpur
- Rana Hospital Pvt Ltd, Gorakhpur
- SRM Medical College Hospital & Research Centre, Kattankulathur (Chengalpattu district)
- Nizam’s Institute of Medical Sciences, Hyderabad
- Gangadhar Sahoo / E Venkata Rao (of Institute of Medical Sciences and SUM Hospital), Bhubaneswar
- Prakhar Hospital Pvt Ltd, Kanpur
- Consultant physicial Sagar Vivek Redkar, Pernem (Goa)
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.jpg)
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.